Exane Derivatives’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $1.88M | Buy |
10,612
+4,965
| +88% | +$881K | 1.08% | 18 |
|
|
2022
Q1 | $1M | Sell |
5,647
-3,810
| -40% | -$675K | 0.28% | 92 |
|
|
2021
Q4 | $1.62M | Sell |
9,457
-2,386
| -20% | -$408K | 0.39% | 50 |
|
|
2021
Q3 | $1.91M | Buy |
11,843
+2,450
| +26% | +$396K | 0.46% | 37 |
|
|
2021
Q2 | $1.59M | Sell |
9,393
-4,517
| -32% | -$765K | 0.36% | 55 |
|
|
2021
Q1 | $2.29M | Buy |
13,910
+7,765
| +126% | +$1.28M | 0.65% | 34 |
|
|
2020
Q4 | $967K | Buy |
6,145
+4,105
| +201% | +$646K | 0.28% | 88 |
|
|
2020
Q3 | $304K | Buy |
2,040
+216
| +12% | +$32.2K | 0.09% | 164 |
|
|
2020
Q2 | $256K | Buy |
1,824
+755
| +71% | +$106K | 0.07% | 190 |
|
|
2020
Q1 | $140K | Sell |
1,069
-419
| -28% | -$54.9K | 0.04% | 222 |
|
|
2019
Q4 | $219K | Buy |
+1,488
| New | +$219K | 0.04% | 230 |
|
|
2016
Q3 | – | Sell |
-2,027
| Closed | -$246K | – | 591 |
|
|
2016
Q2 | $246K | Buy |
+2,027
| New | +$246K | 0.04% | 190 |
|
|
2016
Q1 | – | Sell |
-5,285
| Closed | -$543K | – | 543 |
|
|
2015
Q4 | $543K | Sell |
5,285
-7,106
| -57% | -$730K | 0.07% | 99 |
|
|
2015
Q3 | $1.16M | Buy |
12,391
+1,973
| +19% | +$184K | 0.15% | 66 |
|
|
2015
Q2 | $1.02M | Buy |
10,418
+5,249
| +102% | +$512K | 0.11% | 77 |
|
|
2015
Q1 | $520K | Buy |
5,169
+75
| +1% | +$7.55K | 0.06% | 122 |
|
|
2014
Q4 | $533K | Buy |
+5,094
| New | +$533K | 0.07% | 118 |
|